Table 5.
Cardiometabolic risk changes (n=13)
| Metabolic risk cut-offs | Having metabolic risk n (%) |
Mean ± SD | p- value |
Effect size | |||
|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | ||||
| BMI | Obesity ≥ 35.0 | 41.0±7.3 (ranges: 31.0 – 51.3) |
40.1±7.0 (ranges : 30.7–51.8) |
.027 | −0.13 | ||
| Weight (pound) | N/A | 255.9 ± 56.2 (ranges : 186.3– 363.8) |
249.5±51.5 (ranges : 184.3 – 340.2) |
.031 | −0.12 | ||
| Systolic blood pressure (mmHg) | ≥130mmHg | 4 | 2 | 124.9±17.5 (ranges :105–161) |
117.5±16.8 (ranges : 82–149) |
.052 | −0.43 |
| Diastolic blood pressure (mmHg) | ≥ 85 mmHg | 2 | 2 | 76.3 ±14.6 (ranges: 56–109) |
74.7±11.7 (ranges:61–103) |
.665 | −0.12 |
| Fasting glucose (mg/dL) | ≥100mg/dL | 3 | 3 | 92.5±11.3 (ranges: 81–118) |
97.6±14.3 (ranges: 82–140) |
.112 | 0.39 |
| A1C (%) | ≥ 5.7% | 11 | 6 | 6.0±0.5 (ranges: 5.2–6.8) |
5.6±.5 (ranges: 4.9–7.0) |
.007 | −0.76 |
| Insulin (mmol) | N/A | N/A | N/A | 28.2±13.1 (ranges:15.3–64.7) |
26.4±15.5 (ranges: 16.2–63.9) |
.497 | −0.13 |
| hsCRP | N/A | N/A | N/A | 8.5±9.5 (ranges: 1.6–37.8) |
7.7±6.0 (ranges :1.7 – 22.4) |
.614 | −0.09 |
| Total cholesterol (mg/dL) | ≥200 mg/dL | 3 | 3 | 182.3±23.9 (ranges : 134–221) |
184.9±18.8 (ranges: 155–224) |
.636 | 0.12 |
| Triglyceride(mg/dL) | ≥150 mg/dL | 2 | 2 | 97.9±48.6 (ranges: 39–208) |
109.5±61.4 (ranges : 45–246) |
.318 | 0.21 |
| LDL (mg/dL) | ≥100mg/dL | 8 | 10 | 114.3±26.3 (ranges:78–151) |
117.0±18.3 (ranges:89–150) |
.520 | 0.12 |
| HDL (mg/dL) | < 40 in men; < 50 in women |
48.5±13.2 (31–71) |
46.2±8.9 (29–62) |
.367 | −0.21 | ||